FASLG and autoimmune polyendocrinopathy: This observation seems to reflect 2019 EULAR guidelines that recommend low-dose acetylsalicylic acid in non-pregnant women with a history of obstetric APS (after risk/benefit evaluation) as well as in pregnant women with a high-risk aPL profile without a prior history of thrombosis nor pregnancy complications (25).